Skip to main content

Therapy and clinical trials.

Publication ,  Journal Article
Elmallah, W; Krasuski, RA
Published in: Curr Opin Lipidol
December 2011

Duke Scholars

Published In

Curr Opin Lipidol

DOI

EISSN

1473-6535

Publication Date

December 2011

Volume

22

Issue

6

Start / End Page

512 / 513

Location

England

Related Subject Headings

  • Sulfhydryl Compounds
  • Randomized Controlled Trials as Topic
  • Niacin
  • Hypolipidemic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Esters
  • Drug Therapy, Combination
  • Diabetes Mellitus
  • Coronary Artery Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Elmallah, W., & Krasuski, R. A. (2011). Therapy and clinical trials. Curr Opin Lipidol, 22(6), 512–513. https://doi.org/10.1097/MOL.0b013e32834d208d
Elmallah, Wael, and Richard A. Krasuski. “Therapy and clinical trials.Curr Opin Lipidol 22, no. 6 (December 2011): 512–13. https://doi.org/10.1097/MOL.0b013e32834d208d.
Elmallah W, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2011 Dec;22(6):512–3.
Elmallah, Wael, and Richard A. Krasuski. “Therapy and clinical trials.Curr Opin Lipidol, vol. 22, no. 6, Dec. 2011, pp. 512–13. Pubmed, doi:10.1097/MOL.0b013e32834d208d.
Elmallah W, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2011 Dec;22(6):512–513.

Published In

Curr Opin Lipidol

DOI

EISSN

1473-6535

Publication Date

December 2011

Volume

22

Issue

6

Start / End Page

512 / 513

Location

England

Related Subject Headings

  • Sulfhydryl Compounds
  • Randomized Controlled Trials as Topic
  • Niacin
  • Hypolipidemic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Esters
  • Drug Therapy, Combination
  • Diabetes Mellitus
  • Coronary Artery Disease